XML 75 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues $ 0 $ 458
Cost of sales 0 (346)
Gross profit 0 112
Operating expenses:    
Research and development (Note 11) 17,216 49,283
Selling, general and administrative 50,353 26,579
Total operating expenses 67,569 75,862
Operating loss (67,569) (75,750)
Other income/(expense):    
Research and development tax credit 1,104 9,634
Loss on extinguishment of debt 0 (815)
Interest income 12,761 2,821
Interest expense (2,057) (521)
Foreign exchange gain/(loss) 1,866 (3,817)
Total other income, net 13,674 7,302
Loss before income taxes (53,895) (68,448)
Income tax expense (474) (253)
Net loss $ (54,369) $ (68,701)
Loss per ordinary share, basic (in dollars per share) $ (0.09) $ (0.13)
Loss per ordinary share, diluted (in dollars per share) $ (0.09) $ (0.13)
Weighted-average shares outstanding - basic (in shares) 634,142,660 529,071,526
Weighted-average shares outstanding - diluted (in shares) 634,142,660 529,071,526